This is to inform that due to some circumstances beyond the organizer control, “3rd Edition of International Conference on COPD and Lung Diseases” (COPD 2025) during June 09-11, 2025 at Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, Please contact us at copd@magnusconference.com or call + +1 (702)-988-2320.
Surgery to replace one or both damaged lungs with healthy lungs from a human donor is known as a lung transplant. The new lung or lungs are usually donated by a person under the age of 65 who is brain-dead but still on life support. The donor lungs must be disease-free and match your tissue type as precisely as feasible. This lowers the chances of the transplant being rejected by the body. Living donors can also donate lungs. A group of two or more people is required. Each individual contributes a lobe of their lung. For the person who receives it, this forms a whole lung. Lung transplantation is a serious procedure. It is potentially very dangerous. Organ rejection is the most serious risk of a lung transplant. The medications intended to prevent rejection can also have major side effects. Immunosuppressants are the term for these drugs. Lung transplant patients' survival rates have increased in recent years. Single-lung transplants have a one-year survival rate of over 80%, according to the National Heart, Lung, and Blood Institute (NHLBI)Trusted Source. The five-year survival rate is well above 50%. Those figures were significantly lower 20 years ago. Lung transplant patients' survival rates have increased in recent years.
Important Alert:
X